ProPhase Labs (PRPH) EBITDA (2010 - 2025)
ProPhase Labs (PRPH) EBITDA from Jun 30, 2010 to Sep 30, 2025. The TTM ProPhase Labs (PRPH) EBITDA is -$25M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
ProPhase Labs (PRPH) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -4.12% |
| 5 Years TTM | +73.15% |
| 10 Years TTM | +24.74% |
| All Time TTM | +25.75% |
Annual EBITDA change of ProPhase Labs (PRPH)
| Year | EBITDA | Change |
|---|---|---|
| 2025 | -$9.13M | -71.86% |
| 2024 | -$32M | +113.84% |
| 2023 | -$15M | -153.59% |
| 2022 | $28M | +117.10% |
| 2021 | $13M | -900.00% |
| 2020 | -$1.63M | -42.61% |
| 2019 | -$2.84M | +127.20% |
| 2018 | -$1.25M | -65.75% |
| 2017 | -$3.65M | +63.68% |
| 2016 | -$2.23M | -30.75% |
| 2015 | -$3.22M | -57.35% |
| 2014 | -$7.55M | -1243.94% |
| 2013 | $660K | -177.65% |
| 2012 | -$850K | -64.29% |
| 2011 | -$2.38M | -26.32% |
| 2010 | -$3.23M | -5.28% |
| 2009 | -$3.41M | N/A |
Comparison ProPhase Labs (PRPH) five years EBITDA CAGR with competitors
ProPhase Labs (PRPH) five years EBITDA CAGR is 73.15%.
| Ticker | Name | five years EBITDA CAGR | Upside |
|---|---|---|---|
| MEDP | Medpace Holdings Inc | 25.16% | -65.61% |
| ISPC | iSpecimen Inc | 25.14% | -65.64% |
| PSNL | Personalis Inc | 18.83% | -74.26% |
| WAT | Waters Corp | 17.45% | -76.14% |
| BNR | Burning Rock Biotech Ltd | 17.26% | -76.40% |
| ICLR | Icon Plc | 12.53% | -82.87% |
| IDXX | Idexx Laboratories Inc | 11.66% | -84.06% |
| CSTL | Castle Biosciences Inc | 10.29% | -85.94% |
| MTD | Mettler-Toledo International Inc | 9.87% | -86.51% |
| MYNZ | Mainz Biomed N.V. | 9.82% | -86.58% |
| IQV | IQVIA Holdings Inc | 9.14% | -87.50% |
| RDNT | Radnet Inc | 8.38% | -88.54% |
| IMDX | Insight Molecular Diagnostics Inc | 7.62% | -89.59% |
| ILMN | Illumina Inc | 5.98% | -91.82% |
| A | Agilent Technologies Inc | 5.87% | -91.98% |
| GH | Guardant Health Inc | 5.67% | -92.25% |
| NTRA | Natera Inc | 3.35% | -95.42% |
| TWST | Twist Bioscience Corp | 2.84% | -96.12% |
| BDSX | Biodesix Inc | 2.43% | -96.67% |
| SHC | Sotera Health Company | 2.32% | -96.83% |
| QGEN | Qiagen NV | 2.21% | -96.99% |